[1]
R. M. Leite, “Tumor-infiltrating lymphocytes as prognostic markers in a Brazilian population with neoadjuvant chemotherapy-treated breast cancer: a survival study”, MAST, vol. 35, no. suppl.1, Feb. 2026.